Physician profile
Anna Hsu
NPI 1811554207
$2,401.16
in general payments reported to CMS, 2019-2025
11 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $774 · 2023: $1,319 · 2024: $70.00 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,498.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $634.45 | 2022-2023 | Inspire |
| Glaxosmithkline, LLC. | $525.66 | 2021-2023 | Nucala |
| Aerin Medical INC. | $382.08 | 2023-2025 | |
| Abbvie INC. | $211.64 | 2023 | |
| Alk-Abello, INC | $199.43 | 2022-2023 | Grastek, Odactra, Ragwitek |
| Regeneron Healthcare Solutions, INC. | $166.80 | 2022-2023 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $104.32 | 2023 | |
| Genzyme Corporation | $102.91 | 2022-2023 | |
| Optinose US, INC. | $34.54 | 2023 | |
| Smith+Nephew, INC. | $21.29 | 2022 | |
| Stryker Corporation | $18.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.